Roxicodone and Wound dehiscence - a phase IV clinical study of FDA data

Summary:

Wound dehiscence is reported as a side effect among people who take Roxicodone (oxycodone hydrochloride), especially for people who are male, 30-39 old, also take Neurontin, and have Osteoporosis.

The phase IV clinical study analyzes which people have Wound dehiscence when taking Roxicodone. It is created by eHealthMe based on reports of 19,861 people who have side effects when taking Roxicodone from the FDA, and is updated regularly.

What is Roxicodone?

Roxicodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 20,099 Roxicodone users. Check the latest studies of Roxicodone.

What is Wound dehiscence?

Wound dehiscence (a surgical incision reopens either internally or externally) is found to be associated with 649 drugs and 676 conditions by eHealthMe. Check the latest studies of Wound dehiscence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

19,861 people reported to have side effects when taking Roxicodone.
Among them, 23 people (0.12%) have Wound dehiscence.

Could Roxicodone cause Wound dehiscence?

Among these 23 people:

What is the gender of people who have Wound dehiscence when taking Roxicodone? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Wound dehiscence when taking Roxicodone? *

What are other drugs people take besides Roxicodone? *

Oxycontin: 18 people, 78.26%
Ambien: 18 people, 78.26%
Prednisone: 18 people, 78.26%
Neurontin: 18 people, 78.26%
Acetaminophen And Hydrocodone Bitartrate: 17 people, 73.91%
Androgel: 17 people, 73.91%
Celebrex: 17 people, 73.91%
Diazepam: 17 people, 73.91%
Diflucan: 17 people, 73.91%
Prilosec: 17 people, 73.91%

What are other side effects people have besides Wound dehiscence? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 18 people, 78.26%
Joint Crepitation: 17 people, 73.91%
Soft Tissue Disorder (disease of soft tissue): 17 people, 73.91%
Oral Pain: 17 people, 73.91%
Dry Mouth: 17 people, 73.91%
Pulmonary Embolism (blockage of the main artery of the lung): 17 people, 73.91%
Bone Disorder: 17 people, 73.91%
Back Disorder: 17 people, 73.91%
Osteonecrosis Of Jaw (death of bone of jaw): 17 people, 73.91%
Jaw Disorder (jaw disease): 17 people, 73.91%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 17 people, 73.91%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 8.70%
Stress Gastritis (swelling (inflammation) and weakening of the stomach lining that occurs during a serious illness): 1 person, 4.35%
Insomnia (sleeplessness): 1 person, 4.35%
Breakthrough Pain: 1 person, 4.35%
Enlarged Prostate: 1 person, 4.35%
Gastric Ulcer (stomach ulcer): 1 person, 4.35%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 1 person, 4.35%
High Blood Pressure: 1 person, 4.35%
Hypersensitivity: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Roxicodone and have Wound dehiscence?

- Check whether Wound dehiscence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Roxicodone:

Roxicodone (20,099 reports)

Browse all side effects of Roxicodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Wound dehiscence:

Wound dehiscence (649 drugs)

Browse all the conditions that are associated with Wound dehiscence:

Wound dehiscence (676 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride (the active ingredients of Roxicodone) and Roxicodone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.